These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

376 related articles for article (PubMed ID: 25772939)

  • 1. Distress in relation to attenuated psychotic symptoms in the ultra-high-risk population is not associated with increased risk of psychotic disorder.
    Power L; Polari AR; Yung AR; McGorry PD; Nelson B
    Early Interv Psychiatry; 2016 Jun; 10(3):258-62. PubMed ID: 25772939
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sources of clinical distress in young people at ultra high risk of psychosis.
    Rapado-Castro M; McGorry PD; Yung A; Calvo A; Nelson B
    Schizophr Res; 2015 Jun; 165(1):15-21. PubMed ID: 25890793
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mapping the onset of psychosis: the Comprehensive Assessment of At-Risk Mental States.
    Yung AR; Yuen HP; McGorry PD; Phillips LJ; Kelly D; Dell'Olio M; Francey SM; Cosgrave EM; Killackey E; Stanford C; Godfrey K; Buckby J
    Aust N Z J Psychiatry; 2005; 39(11-12):964-71. PubMed ID: 16343296
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of distress related to attenuated psychotic symptoms in individuals at ultra high risk of psychosis: Findings from the Longitudinal Youth at Risk Study.
    Rekhi G; Rapisarda A; Lee J
    Early Interv Psychiatry; 2019 Feb; 13(1):73-78. PubMed ID: 28560723
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Assessment of mental states at risk of psychotic transition: validation of the French version of the CAARMS].
    Krebs MO; Magaud E; Willard D; Elkhazen C; Chauchot F; Gut A; Morvan Y; Bourdel MC; Kazes M
    Encephale; 2014 Dec; 40(6):447-56. PubMed ID: 25127895
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Persistence or recurrence of non-psychotic comorbid mental disorders associated with 6-year poor functional outcomes in patients at ultra high risk for psychosis.
    Rutigliano G; Valmaggia L; Landi P; Frascarelli M; Cappucciati M; Sear V; Rocchetti M; De Micheli A; Jones C; Palombini E; McGuire P; Fusar-Poli P
    J Affect Disord; 2016 Oct; 203():101-110. PubMed ID: 27285723
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Detection and early treatment of subjects at high risk of clinical psychosis: Definitions and recommendations].
    Michel C; Toffel E; Schmidt SJ; Eliez S; Armando M; Solida-Tozzi A; Schultze-Lutter F; Debbané M
    Encephale; 2017 May; 43(3):292-297. PubMed ID: 28347521
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adolescents at ultra-high risk of psychosis in Italian neuropsychiatry services: prevalence, psychopathology and transition rate.
    Pelizza L; Azzali S; Garlassi S; Paterlini F; Scazza I; Chiri LR; Pupo S; Raballo A
    Eur Child Adolesc Psychiatry; 2018 Jun; 27(6):725-737. PubMed ID: 29058115
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of psychiatric comorbidity in individuals at Ultra High Risk of psychosis - Findings from the Longitudinal Youth at Risk Study (LYRIKS).
    Lim J; Rekhi G; Rapisarda A; Lam M; Kraus M; Keefe RS; Lee J
    Schizophr Res; 2015 May; 164(1-3):8-14. PubMed ID: 25818728
    [TBL] [Abstract][Full Text] [Related]  

  • 10. State marker properties of niacin skin sensitivity in ultra-high risk groups for psychosis - An optical reflection spectroscopy study.
    Langbein K; Schmidt U; Schack S; Biesel NJ; Rudzok M; Amminger GP; Berger M; Sauer H; Smesny S
    Schizophr Res; 2018 Feb; 192():377-384. PubMed ID: 28602647
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk factors for psychosis in an ultra high-risk group: psychopathology and clinical features.
    Yung AR; Phillips LJ; Yuen HP; McGorry PD
    Schizophr Res; 2004 Apr; 67(2-3):131-42. PubMed ID: 14984872
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Baseline differences in clinical symptomatology between ultra high risk subjects with and without a transition to psychosis.
    Velthorst E; Nieman DH; Becker HE; van de Fliert R; Dingemans PM; Klaassen R; de Haan L; van Amelsvoort T; Linszen DH
    Schizophr Res; 2009 Apr; 109(1-3):60-5. PubMed ID: 19272756
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early psychotic experiences: Interventions, problems and perspectives.
    Dimitrakopoulos S; Kollias C; Stefanis NC; Kontaxakis V
    Psychiatriki; 2015; 26(1):45-54. PubMed ID: 25880383
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Attenuated psychotic and basic symptom characteristics in adolescents with ultra-high risk criteria for psychosis, other non-psychotic psychiatric disorders and early-onset psychosis.
    Lo Cascio N; Saba R; Hauser M; Vernal DL; Al-Jadiri A; Borenstein Y; Sheridan EM; Kishimoto T; Armando M; Vicari S; Fiori Nastro P; Girardi P; Gebhardt E; Kane JM; Auther A; Carrión RE; Cornblatt BA; Schimmelmann BG; Schultze-Lutter F; Correll CU
    Eur Child Adolesc Psychiatry; 2016 Oct; 25(10):1091-102. PubMed ID: 26921232
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adolescents at ultra-high risk for psychosis with and without 22q11 deletion syndrome: a comparison of prodromal psychotic symptoms and general functioning.
    Armando M; Girardi P; Vicari S; Menghini D; Digilio MC; Pontillo M; Saba R; Mazzone L; Lin A; Klier CM; Schäfer MR; Amminger GP
    Schizophr Res; 2012 Aug; 139(1-3):151-6. PubMed ID: 22627123
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The approved Italian version of the comprehensive assessment of at-risk mental states (CAARMS-ITA): Field test and psychometric features.
    Pelizza L; Paterlini F; Azzali S; Garlassi S; Scazza I; Pupo S; Simmons M; Nelson B; Raballo A
    Early Interv Psychiatry; 2019 Aug; 13(4):810-817. PubMed ID: 29696795
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Psychotic conversion of individuals at ultra-high risk for psychosis: The potential roles of schizotypy and basic symptoms.
    Bang M; Park JY; Kim KR; Lee SY; Song YY; Kang JI; Lee E; An SK
    Early Interv Psychiatry; 2019 Jun; 13(3):546-554. PubMed ID: 29218852
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The significance of at-risk symptoms for psychosis in children and adolescents.
    Schimmelmann BG; Walger P; Schultze-Lutter F
    Can J Psychiatry; 2013 Jan; 58(1):32-40. PubMed ID: 23327754
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term follow-up of a group at ultra high risk ("prodromal") for psychosis: the PACE 400 study.
    Nelson B; Yuen HP; Wood SJ; Lin A; Spiliotacopoulos D; Bruxner A; Broussard C; Simmons M; Foley DL; Brewer WJ; Francey SM; Amminger GP; Thompson A; McGorry PD; Yung AR
    JAMA Psychiatry; 2013 Aug; 70(8):793-802. PubMed ID: 23739772
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Ultra-High-Risk for psychosis groups: Evidence to maintain the status quo.
    McHugh MJ; McGorry PD; Yuen HP; Hickie IB; Thompson A; de Haan L; Mossaheb N; Smesny S; Lin A; Markulev C; Schloegelhofer M; Wood SJ; Nieman D; Hartmann JA; Nordentoft M; Schäfer M; Amminger GP; Yung A; Nelson B
    Schizophr Res; 2018 May; 195():543-548. PubMed ID: 29055567
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.